Last February, the serving White House (WH) Chief of Staff (COS) quietly resigned, and a new one was ushered in. But a comparison of the outgoing and incoming WH Chief of Staff demonstrates striking similarities. A careful reading of the bios of Biden's two chief of staff picks reveals a disturbing trend. Both choices appear consistent with - first and foremost - the capture of both the "health"-related administrative state and the levers of the Biden administration itself by the pharmaceutical-medical industrial complex.

Why is this important? Because the WH Chief of Staff is the most critical political appointee of the President, and functionally serves as the head of the Executive Office of the President of the United States in addition to being a cabinet position. The position is widely considered the most important and powerful job in the Executive branch of the US Government, next to the sitting POTUS.

In the case of a feeble or incapacitated president, the WH Chief of Staff essentially acts in place of the President. Given the ascendency of the power of the Executive Branch and its permanent Administrative State bureaucracy over the judicial and legislative branches, this appointed position functionally runs the country.